Thetis Pharmaceuticals Receives $1,434,000 New Funding Round

  • Feed Type
  • Date
    2/12/2016
  • Company Name
    Thetis Pharmaceuticals
  • Mailing Address
    167 Old Post Rd 2nd Floor Southport, CT 06890 USA
  • Company Description
    Thetis Pharmaceuticals is a privately held biopharmaceutical company applying its HEALER technology to discover and develop innovative drugs for the treatment of gastrointestinal and cardiometabolic diseases. Using HEALER, Thetis transforms fatty acids into small molecule pharmaceuticals with composition of matter patent protection.
  • Website
    http://www.thetispharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,434,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy